{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:46:25Z","timestamp":1793015185574,"version":"4.5.0"},"reference-count":175,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1038\/s41575-021-00419-3","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T04:02:53Z","timestamp":1613793773000},"page":"432-443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":316,"title":["Global burden and epidemiology of Barrett oesophagus and oesophageal cancer"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0084-5308","authenticated-orcid":false,"given":"Aaron P.","family":"Thrift","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"key":"419_CR1","unstructured":"World Health Organization. Cancer Today: Data visualization tools for exploring the global cancer burden in 2020. https:\/\/gco.iarc.fr\/today\/home (2020)."},{"key":"419_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"419_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2019. CA Cancer J. Clin. 69, 7\u201334 (2019).","journal-title":"CA Cancer J. Clin."},{"key":"419_CR4","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1007\/s10620-018-5068-6","volume":"63","author":"AP Thrift","year":"2018","unstructured":"Thrift, A. P. Barrett\u2019s esophagus and esophageal adenocarcinoma: how common are they really? Dig. Dis. Sci. 63, 1988\u20131996 (2018).","journal-title":"Dig. Dis. Sci."},{"key":"419_CR5","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/j.ejca.2015.07.026","volume":"51","author":"LA Anderson","year":"2015","unstructured":"Anderson, L. A. et al. Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: results from EUROCARE-5. Eur. J. Cancer 51, 2144\u20132157 (2015).","journal-title":"Eur. J. Cancer"},{"key":"419_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/gutjnl-2014-308124","volume":"64","author":"M Arnold","year":"2015","unstructured":"Arnold, M., Soerjomataram, I., Ferlay, J. & Forman, D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut 64, 381\u2013387 (2015).","journal-title":"Gut"},{"key":"419_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/jnci\/dji024","volume":"97","author":"H Pohl","year":"2005","unstructured":"Pohl, H. & Welch, H. G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J. Natl Cancer Inst. 97, 142\u2013146 (2005).","journal-title":"J. Natl Cancer Inst."},{"key":"419_CR8","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1093\/annonc\/mds181","volume":"23","author":"AP Thrift","year":"2012","unstructured":"Thrift, A. P. & Whiteman, D. C. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann. Oncol. 23, 3155\u20133162 (2012).","journal-title":"Ann. Oncol."},{"key":"419_CR9","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1136\/gutjnl-2012-302412","volume":"62","author":"G Edgren","year":"2013","unstructured":"Edgren, G., Adami, H. O., Weiderpass, E. & Nyren, O. A global assessment of the oesophageal adenocarcinoma epidemic. Gut 62, 1406\u20131414 (2013).","journal-title":"Gut"},{"key":"419_CR10","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1111\/j.1572-0241.2006.00548.x","volume":"101","author":"BJ Kendall","year":"2006","unstructured":"Kendall, B. J. & Whiteman, D. C. Temporal changes in the endoscopic frequency of new cases of Barrett\u2019s esophagus in an Australian health region. Am. J. Gastroenterol. 101, 1178\u20131182 (2006).","journal-title":"Am. J. Gastroenterol."},{"key":"419_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cgh.2018.07.018","volume":"17","author":"J Dong","year":"2019","unstructured":"Dong, J., Gu, X., El-Serag, H. B. & Thrift, A. P. Underuse of surgery accounts for racial disparities in esophageal cancer survival times: a matched cohort study. Clin. Gastroenterol. Hepatol. 17, 657\u2013665 (2019).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"419_CR12","unstructured":"Bray, F. et al. (eds) Cancer Incidence in Five Continents, Vol. XI (Electronic Version) (International Agency for Research on Cancer, 2017)."},{"key":"419_CR13","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/ajg.2017.155","volume":"112","author":"M Arnold","year":"2017","unstructured":"Arnold, M., Laversanne, M., Brown, L. M., Devesa, S. S. & Bray, F. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. Am. J. Gastroenterol. 112, 1247\u20131255 (2017).","journal-title":"Am. J. Gastroenterol."},{"key":"419_CR14","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/s41416-018-0047-4","volume":"118","author":"J Offman","year":"2018","unstructured":"Offman, J., Pesola, F. & Sasieni, P. Trends and projections in adenocarcinoma and squamous cell carcinoma of the oesophagus in England from 1971 to 2037. Br. J. Cancer 118, 1391\u20131398 (2018).","journal-title":"Br. J. Cancer"},{"key":"419_CR15","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2147\/CLEP.S166078","volume":"10","author":"QL Wang","year":"2018","unstructured":"Wang, Q. L., Xie, S. H., Wahlin, K. & Lagergren, J. Global time trends in the incidence of esophageal squamous cell carcinoma. Clin. Epidemiol. 10, 717\u2013728 (2018).","journal-title":"Clin. Epidemiol."},{"key":"419_CR16","doi-asserted-by":"publisher","first-page":"38876","DOI":"10.18632\/oncotarget.9113","volume":"7","author":"SH Xie","year":"2016","unstructured":"Xie, S. H. & Lagergren, J. A global assessment of the male predominance in esophageal adenocarcinoma. Oncotarget 7, 38876\u201338883 (2016).","journal-title":"Oncotarget"},{"key":"419_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cgh.2015.10.005","volume":"14","author":"SH Xie","year":"2016","unstructured":"Xie, S. H. & Lagergren, J. The male predominance in esophageal adenocarcinoma. Clin. Gastroenterol. Hepatol. 14, 338\u2013347 (2016).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"419_CR18","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.cgh.2015.10.028","volume":"14","author":"AP Thrift","year":"2016","unstructured":"Thrift, A. P. & El-Serag, H. B. Sex and racial disparity in incidence of esophageal adenocarcinoma: observations and explanations. Clin. Gastroenterol. Hepatol. 14, 330\u2013332 (2016).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"419_CR19","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/sj.bjc.6605246","volume":"101","author":"MB Cook","year":"2009","unstructured":"Cook, M. B., Chow, W. H. & Devesa, S. S. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977\u20132005. Br. J. Cancer 101, 855\u2013859 (2009).","journal-title":"Br. J. Cancer"},{"key":"419_CR20","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/aje\/kwi325","volume":"162","author":"MB Cook","year":"2005","unstructured":"Cook, M. B., Wild, C. P. & Forman, D. A systematic review and meta-analysis of the sex ratio for Barrett\u2019s esophagus, erosive reflux disease, and nonerosive reflux disease. Am. J. Epidemiol. 162, 1050\u20131061 (2005).","journal-title":"Am. J. Epidemiol."},{"key":"419_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/2050640617751254","volume":"6","author":"SH Xie","year":"2018","unstructured":"Xie, S. H. & Lagergren, J. Social group disparities in the incidence and prognosis of oesophageal cancer. U Eur. Gastroenterol. J. 6, 343\u2013348 (2018).","journal-title":"U Eur. Gastroenterol. J."},{"key":"419_CR22","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1097\/CEJ.0000000000000308","volume":"26","author":"G Launoy","year":"2017","unstructured":"Launoy, G., Bossard, N., Castro, C. & Manfredi, S. Trends in net survival from esophageal cancer in six European Latin countries: results from the SUDCAN population-based study. Eur. J. Cancer Prev. 26, S24\u2013S31 (2017).","journal-title":"Eur. J. Cancer Prev."},{"key":"419_CR23","unstructured":"Surveillance, Epidemiology, and End Rresults Program. SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2018 Sub (1975-2016) <Katrina\/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969-2017 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2019, based on the2018 submission (National Cancer Institute, 2020)."},{"key":"419_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.canep.2016.01.013","volume":"41","author":"AP Thrift","year":"2016","unstructured":"Thrift, A. P. The epidemic of oesophageal carcinoma: where are we now? Cancer Epidemiol. 41, 88\u201395 (2016).","journal-title":"Cancer Epidemiol."},{"key":"419_CR25","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1200\/JCO.2005.05.169","volume":"23","author":"EW Steyerberg","year":"2005","unstructured":"Steyerberg, E. W., Earle, C. C., Neville, B. A. & Weeks, J. C. Racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: a population-based analysis of elderly patients. J. Clin. Oncol. 23, 510\u2013517 (2005).","journal-title":"J. Clin. Oncol."},{"key":"419_CR26","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJMcp012118","volume":"346","author":"SJ Spechler","year":"2002","unstructured":"Spechler, S. J. Clinical practice. Barrett\u2019s esophagus. N. Engl. J. Med. 346, 836\u2013842 (2002).","journal-title":"N. Engl. J. Med."},{"key":"419_CR27","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1053\/j.gastro.2005.08.053","volume":"129","author":"J Ronkainen","year":"2005","unstructured":"Ronkainen, J. et al. Prevalence of Barrett\u2019s esophagus in the general population: an endoscopic study. Gastroenterology 129, 1825\u20131831 (2005).","journal-title":"Gastroenterology"},{"key":"419_CR28","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/gutjnl-2016-312223","volume":"67","author":"MB Cook","year":"2018","unstructured":"Cook, M. B. et al. Cancer incidence and mortality risks in a large US Barrett\u2019s oesophagus cohort. Gut 67, 418\u2013529 (2018).","journal-title":"Gut"},{"key":"419_CR29","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1136\/gutjnl-2011-300730","volume":"61","author":"TK Desai","year":"2012","unstructured":"Desai, T. K. et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett\u2019s oesophagus: a meta-analysis. Gut 61, 970\u2013976 (2012).","journal-title":"Gut"},{"key":"419_CR30","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.gie.2007.07.019","volume":"67","author":"A Rastogi","year":"2008","unstructured":"Rastogi, A. et al. Incidence of esophageal adenocarcinoma in patients with Barrett\u2019s esophagus and high-grade dysplasia: a meta-analysis. Gastrointest. Endosc. 67, 394\u2013398 (2008).","journal-title":"Gastrointest. Endosc."},{"key":"419_CR31","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1093\/jnci\/djg047","volume":"95","author":"LS Engel","year":"2003","unstructured":"Engel, L. S. et al. Population attributable risks of esophageal and gastric cancers. J. Natl Cancer Inst. 95, 1404\u20131413 (2003).","journal-title":"J. Natl Cancer Inst."},{"key":"419_CR32","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/aje\/kwr117","volume":"174","author":"CM Olsen","year":"2011","unstructured":"Olsen, C. M., Pandeya, N., Green, A. C., Webb, P. M. & Whiteman, D. C. Population attributable fractions of adenocarcinoma of the esophagus and gastroesophageal junction. Am. J. Epidemiol. 174, 582\u2013590 (2011).","journal-title":"Am. J. Epidemiol."},{"key":"419_CR33","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1158\/1055-9965.EPI-15-0323-T","volume":"24","author":"WD Hazelton","year":"2015","unstructured":"Hazelton, W. D. et al. The role of gastroesophageal reflux and other factors during progression to esophageal adenocarcinoma. Cancer Epidemiol. Biomarkers Prev. 24, 1012\u20131023 (2015).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"419_CR34","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.canep.2013.05.011","volume":"37","author":"N Pandeya","year":"2013","unstructured":"Pandeya, N., Olsen, C. M. & Whiteman, D. C. Sex differences in the proportion of esophageal squamous cell carcinoma cases attributable to tobacco smoking and alcohol consumption. Cancer Epidemiol. 37, 579\u2013584 (2013).","journal-title":"Cancer Epidemiol."},{"key":"419_CR35","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1053\/j.gastro.2018.12.024","volume":"156","author":"M Sheikh","year":"2019","unstructured":"Sheikh, M. et al. Individual and combined effects of environmental risk factors for esophageal cancer based on results from the Golestan Cohort Study. Gastroenterology 156, 1416\u20131427 (2019).","journal-title":"Gastroenterology"},{"key":"419_CR36","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJM199903183401101","volume":"340","author":"J Lagergren","year":"1999","unstructured":"Lagergren, J., Bergstrom, R., Lindgren, A. & Nyren, O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 340, 825\u2013831 (1999).","journal-title":"N. Engl. J. Med."},{"key":"419_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103508","volume":"9","author":"MB Cook","year":"2014","unstructured":"Cook, M. B. et al. Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett\u2019s and Esophageal Adenocarcinoma Consortium (BEACON). PLoS ONE 9, e103508 (2014).","journal-title":"PLoS ONE"},{"key":"419_CR38","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/ajg.2013.72","volume":"108","author":"AP Thrift","year":"2013","unstructured":"Thrift, A. P., Kramer, J. R., Qureshi, Z., Richardson, P. A. & El-Serag, H. B. Age at onset of GERD symptoms predicts risk of Barrett\u2019s esophagus. Am. J. Gastroenterol. 108, 915\u2013922 (2013).","journal-title":"Am. J. Gastroenterol."},{"key":"419_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3164\/jcbn.40.13","volume":"40","author":"N Yoshida","year":"2007","unstructured":"Yoshida, N. Inflammation and oxidative stress in gastroesophageal reflux disease. J. Clin. Biochem. Nutr. 40, 13\u201323 (2007).","journal-title":"J. Clin. Biochem. Nutr."},{"key":"419_CR40","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/jnci\/djq289","volume":"102","author":"MB Cook","year":"2010","unstructured":"Cook, M. B. et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J. Natl Cancer Inst. 102, 1344\u20131353 (2010).","journal-title":"J. Natl Cancer Inst."},{"key":"419_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/gut.2009.191080","volume":"59","author":"J Steevens","year":"2010","unstructured":"Steevens, J., Schouten, L. J., Goldbohm, R. A. & van den Brandt, P. A. Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut 59, 39\u201348 (2010).","journal-title":"Gut"},{"key":"419_CR42","doi-asserted-by":"publisher","first-page":"djx115","DOI":"10.1093\/jnci\/djx115","volume":"109","author":"QL Wang","year":"2017","unstructured":"Wang, Q. L., Xie, S. H., Li, W. T. & Lagergren, J. Smoking cessation and risk of esophageal cancer by histological type: systematic review and meta-analysis. J. Natl Cancer Inst. 109, djx115 (2017).","journal-title":"J. Natl Cancer Inst."},{"key":"419_CR43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/aje\/kwn091","volume":"168","author":"N Pandeya","year":"2008","unstructured":"Pandeya, N. et al. Associations of duration, intensity, and quantity of smoking with adenocarcinoma and squamous cell carcinoma of the esophagus. Am. J. Epidemiol. 168, 105\u2013114 (2008).","journal-title":"Am. J. Epidemiol."},{"key":"419_CR44","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/ajg.2014.71","volume":"109","author":"A Prabhu","year":"2014","unstructured":"Prabhu, A., Obi, K. O. & Rubenstein, J. H. The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta-analysis. Am. J. Gastroenterol. 109, 822\u2013827 (2014).","journal-title":"Am. J. Gastroenterol."},{"key":"419_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042281","volume":"7","author":"JB Wang","year":"2012","unstructured":"Wang, J. B. et al. Attributable causes of esophageal cancer incidence and mortality in China. PLoS ONE 7, e42281 (2012).","journal-title":"PLoS ONE"},{"key":"419_CR46","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/bjc.2012.449","volume":"107","author":"NA Dar","year":"2012","unstructured":"Dar, N. A. et al. Hookah smoking, nass chewing, and oesophageal squamous cell carcinoma in Kashmir, India. Br. J. Cancer 107, 1618\u20131623 (2012).","journal-title":"Br. J. Cancer"},{"key":"419_CR47","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1053\/j.gastro.2011.12.049","volume":"142","author":"MB Cook","year":"2012","unstructured":"Cook, M. B. et al. Cigarette smoking increases risk of Barrett\u2019s esophagus: an analysis of the Barrett\u2019s and Esophageal Adenocarcinoma Consortium. Gastroenterology 142, 744\u2013753 (2012).","journal-title":"Gastroenterology"},{"key":"419_CR48","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.cgh.2009.04.018","volume":"7","author":"KJ Smith","year":"2009","unstructured":"Smith, K. J., O\u2019Brien, S. M., Green, A. C., Webb, P. M. & Whiteman, D. C. Current and past smoking significantly increase risk for Barrett\u2019s esophagus. Clin. Gastroenterol. Hepatol. 7, 840\u2013848 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"419_CR49","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1053\/j.gastro.2007.05.026","volume":"133","author":"ZR Edelstein","year":"2007","unstructured":"Edelstein, Z. R., Farrow, D. C., Bronner, M. P., Rosen, S. N. & Vaughan, T. L. Central adiposity and risk of Barrett\u2019s esophagus. Gastroenterology 133, 403\u2013411 (2007).","journal-title":"Gastroenterology"},{"key":"419_CR50","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3748\/wjg.v13.i10.1585","volume":"13","author":"LA Anderson","year":"2007","unstructured":"Anderson, L. A. et al. Risk factors for Barrett\u2019s oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J. Gastroenterol. 13, 1585\u20131594 (2007).","journal-title":"World J. Gastroenterol."},{"key":"419_CR51","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10552-008-9244-4","volume":"20","author":"A Kubo","year":"2009","unstructured":"Kubo, A. et al. Cigarette smoking and the risk of Barrett\u2019s esophagus. Cancer Causes Control. 20, 303\u2013311 (2009).","journal-title":"Cancer Causes Control."},{"key":"419_CR52","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s10620-013-2892-6","volume":"59","author":"AP Thrift","year":"2014","unstructured":"Thrift, A. P., Kramer, J. R., Richardson, P. A. & El-Serag, H. B. No significant effects of smoking or alcohol consumption on risk of Barrett\u2019s esophagus. Dig. Dis. Sci. 59, 108\u2013116 (2014).","journal-title":"Dig. Dis. Sci."},{"key":"419_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052192","volume":"8","author":"S Hardikar","year":"2013","unstructured":"Hardikar, S. et al. The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett\u2019s esophagus. PLoS ONE 8, e52192 (2013).","journal-title":"PLoS ONE"},{"key":"419_CR54","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1053\/j.gastro.2011.10.034","volume":"142","author":"HG Coleman","year":"2012","unstructured":"Coleman, H. G. et al. Tobacco smoking increases the risk of high-grade dysplasia and cancer among patients with Barrett\u2019s esophagus. Gastroenterology 142, 233\u2013240 (2012).","journal-title":"Gastroenterology"},{"key":"419_CR55","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/CEJ.0b013e328350b06f","volume":"21","author":"JR Ramus","year":"2012","unstructured":"Ramus, J. R., Gatenby, P. A., Caygill, C. P., Watson, A. & Winslet, M. C. The relationship between smoking and severe dysplastic disease in patients with Barrett\u2019s columnar-lined oesophagus. Eur. J. Cancer Prev. 21, 507\u2013510 (2012).","journal-title":"Eur. J. Cancer Prev."},{"key":"419_CR56","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1158\/1055-9965.EPI-11-0547","volume":"20","author":"CY Kong","year":"2011","unstructured":"Kong, C. Y. et al. The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model. Cancer Epidemiol. Biomarkers Prev. 20, 2450\u20132456 (2011).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"419_CR57","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/ajg.2013.420","volume":"109","author":"S Kroep","year":"2014","unstructured":"Kroep, S. et al. Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands. Am. J. Gastroenterol. 109, 336\u2013343 (2014).","journal-title":"Am. J. Gastroenterol."},{"key":"419_CR58","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1093\/ije\/dys176","volume":"41","author":"C Hoyo","year":"2012","unstructured":"Hoyo, C. et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the international BEACON consortium. Int. J. Epidemiol. 41, 1706\u20131718 (2012).","journal-title":"Int. J. Epidemiol."},{"key":"419_CR59","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ijc.29432","volume":"137","author":"A Steffen","year":"2015","unstructured":"Steffen, A. et al. General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition. Int. J. Cancer 137, 646\u2013657 (2015).","journal-title":"Int. J. Cancer"},{"key":"419_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-103","volume":"14","author":"B Lindkvist","year":"2014","unstructured":"Lindkvist, B. et al. Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project. BMC Cancer 14, 103 (2014).","journal-title":"BMC Cancer"},{"key":"419_CR61","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s10620-008-0413-9","volume":"53","author":"H El-Serag","year":"2008","unstructured":"El-Serag, H. The association between obesity and GERD: a review of the epidemiological evidence. Dig. Dis. Sci. 53, 2307\u20132312 (2008).","journal-title":"Dig. Dis. Sci."},{"key":"419_CR62","doi-asserted-by":"publisher","first-page":"dju252","DOI":"10.1093\/jnci\/dju252","volume":"106","author":"AP Thrift","year":"2014","unstructured":"Thrift, A. P. et al. Obesity and risk of esophageal adenocarcinoma and Barrett\u2019s esophagus: a Mendelian randomization study. J. Natl Cancer Inst. 106, dju252 (2014).","journal-title":"J. Natl Cancer Inst."},{"key":"419_CR63","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1053\/j.gastro.2017.07.046","volume":"154","author":"HG Coleman","year":"2018","unstructured":"Coleman, H. G., Xie, S. H. & Lagergren, J. The epidemiology of esophageal adenocarcinoma. Gastroenterology 154, 390\u2013405 (2018).","journal-title":"Gastroenterology"},{"key":"419_CR64","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/bjc.2014.646","volume":"112","author":"MB Cook","year":"2015","unstructured":"Cook, M. B., Freedman, N. D., Gamborg, M., Sorensen, T. I. & Baker, J. L. Childhood body mass index in relation to future risk of oesophageal adenocarcinoma. Br. J. Cancer 112, 601\u2013607 (2015).","journal-title":"Br. J. Cancer"},{"key":"419_CR65","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1002\/cncr.28241","volume":"119","author":"Z Levi","year":"2013","unstructured":"Levi, Z. et al. Body mass index and socioeconomic status measured in adolescence, country of origin, and the incidence of gastroesophageal adenocarcinoma in a cohort of 1 million men. Cancer 119, 4086\u20134093 (2013).","journal-title":"Cancer"},{"key":"419_CR66","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.cgh.2013.05.009","volume":"11","author":"S Singh","year":"2013","unstructured":"Singh, S. et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 11, 1399\u20131412 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"419_CR67","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1136\/gutjnl-2012-303753","volume":"62","author":"A Kubo","year":"2013","unstructured":"Kubo, A. et al. Sex-specific associations between body mass index, waist circumference and the risk of Barrett\u2019s oesophagus: a pooled analysis from the international BEACON consortium. Gut 62, 1684\u20131691 (2013).","journal-title":"Gut"},{"key":"419_CR68","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1136\/gutjnl-2012-304189","volume":"63","author":"HB El-Serag","year":"2014","unstructured":"El-Serag, H. B. et al. Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett\u2019s oesophagus: a case-control study. Gut 63, 220\u2013229 (2014).","journal-title":"Gut"},{"key":"419_CR69","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.canep.2014.03.006","volume":"38","author":"BJ Kendall","year":"2014","unstructured":"Kendall, B. J., Macdonald, G. A., Prins, J. B., O\u2019Brien, S. & Whiteman, D. C. Total body fat and the risk of Barrett\u2019s oesophagus \u2013 a bioelectrical impedance study. Cancer Epidemiol. 38, 266\u2013272 (2014).","journal-title":"Cancer Epidemiol."},{"key":"419_CR70","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/MCG.0b013e31829ae98c","volume":"48","author":"AP Thrift","year":"2014","unstructured":"Thrift, A. P., Kramer, J. R., Alsarraj, A. & El-Serag, H. B. Fat mass by bioelectrical impedance analysis is not associated with increased risk of Barrett esophagus. J. Clin. Gastroenterol. 48, 218\u2013223 (2014).","journal-title":"J. Clin. Gastroenterol."},{"key":"419_CR71","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.cgh.2016.05.032","volume":"14","author":"BJ Kendall","year":"2016","unstructured":"Kendall, B. J. et al. Inverse association between gluteofemoral obesity and risk of Barrett\u2019s esophagus in a pooled analysis. Clin. Gastroenterol. Hepatol. 14, 1412\u20131419 (2016).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"419_CR72","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/cncr.26455","volume":"118","author":"PH Lahmann","year":"2012","unstructured":"Lahmann, P. H., Pandeya, N., Webb, P. M., Green, A. C. & Whiteman, D. C. Body mass index, long-term weight change, and esophageal squamous cell carcinoma: is the inverse association modified by smoking status? Cancer 118, 1901\u20131909 (2012).","journal-title":"Cancer"},{"key":"419_CR73","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1136\/gut.2010.233866","volume":"60","author":"ND Freedman","year":"2011","unstructured":"Freedman, N. D. et al. Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON consortium. Gut 60, 1029\u20131037 (2011).","journal-title":"Gut"},{"key":"419_CR74","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/ajg.2014.206","volume":"109","author":"AP Thrift","year":"2014","unstructured":"Thrift, A. P. et al. Alcohol and the risk of Barrett\u2019s esophagus: a pooled analysis from the international BEACON consortium. Am. J. Gastroenterol. 109, 1586\u20131594 (2014).","journal-title":"Am. J. Gastroenterol."},{"key":"419_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105612","volume":"9","author":"Z Lou","year":"2014","unstructured":"Lou, Z., Xing, H. & Li, D. Alcohol consumption and the neoplastic progression in Barrett\u2019s esophagus: a systematic review and meta-analysis. PLoS ONE 9, e105612 (2014).","journal-title":"PLoS ONE"},{"key":"419_CR76","unstructured":"World Cancer Research Fund\/American Institute for Cancer Research. Continuous Update Project Report: Diet, Nutrition, Physical Activity and Oesophageal Cancer Project Expert Report (American Institute for Cancer Research, 2018)."},{"key":"419_CR77","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2008.12.052","volume":"136","author":"N Pandeya","year":"2009","unstructured":"Pandeya, N., Williams, G., Green, A. C., Webb, P. M. & Whiteman, D. C. Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus. Gastroenterology 136, 1215\u20131224 (2009).","journal-title":"Gastroenterology"},{"key":"419_CR78","doi-asserted-by":"publisher","first-page":"893","DOI":"10.14309\/ajg.0000000000000219","volume":"114","author":"M Crous-Bou","year":"2019","unstructured":"Crous-Bou, M., Jovani, M., De Vivo, I. & Jacobson, B. C. Gene-environment interactions and the risk of Barrett\u2019s esophagus in three US cohorts. Am. J. Gastroenterol. 114, 893\u2013899 (2019).","journal-title":"Am. J. Gastroenterol."},{"key":"419_CR79","first-page":"1227","volume":"12","author":"T Yokoyama","year":"2003","unstructured":"Yokoyama, T. et al. Alcohol flushing, alcohol and aldehyde dehydrogenase genotypes, and risk for esophageal squamous cell carcinoma in Japanese men. Cancer Epidemiol. Biomarkers Prev. 12, 1227\u20131233 (2003).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"419_CR80","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1002\/ijc.32204","volume":"145","author":"LF Wilson","year":"2019","unstructured":"Wilson, L. F. et al. The impact of reducing alcohol consumption in Australia: an estimate of the proportion of potentially avoidable cancers 2013-2037. Int. J. Cancer 145, 2944\u20132953 (2019).","journal-title":"Int. J. Cancer"},{"key":"419_CR81","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41568-019-0227-4","volume":"20","author":"SE Steck","year":"2020","unstructured":"Steck, S. E. & Murphy, E. A. Dietary patterns and cancer risk. Nat. Rev. Cancer 20, 125\u2013138 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"419_CR82","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1136\/bjsports-2017-098391","volume":"52","author":"LFM Rezende","year":"2018","unstructured":"Rezende, L. F. M. et al. Physical activity and cancer: an umbrella review of the literature including 22 major anatomical sites and 770\u2009000 cancer cases. Br. J. Sports Med. 52, 826\u2013833 (2018).","journal-title":"Br. J. Sports Med."},{"key":"419_CR83","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1017\/S0007114511004247","volume":"107","author":"TI Ibiebele","year":"2012","unstructured":"Ibiebele, T. I., Hughes, M. C., Whiteman, D. C. & Webb, P. M. Dietary patterns and risk of oesophageal cancers: a population-based case-control study. Br. J. Nutr. 107, 1207\u20131216 (2012).","journal-title":"Br. J. Nutr."},{"key":"419_CR84","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/aje\/kwm381","volume":"167","author":"A Kubo","year":"2008","unstructured":"Kubo, A. et al. Dietary patterns and the risk of Barrett\u2019s esophagus. Am. J. Epidemiol. 167, 839\u2013846 (2008).","journal-title":"Am. J. Epidemiol."},{"key":"419_CR85","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1111\/j.1572-0241.2008.01838.x","volume":"103","author":"A Kubo","year":"2008","unstructured":"Kubo, A. et al. Dietary antioxidants, fruits, and vegetables and the risk of Barrett\u2019s esophagus. Am. J. Gastroenterol. 103, 1614\u20131623 (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"419_CR86","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.cgh.2013.03.023","volume":"11","author":"WQ Li","year":"2013","unstructured":"Li, W. Q. et al. Index-based dietary patterns and risk of esophageal and gastric cancer in a large cohort study. Clin. Gastroenterol. Hepatol. 11, 1130\u20131136 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"419_CR87","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1002\/ijc.25928","volume":"129","author":"J Steevens","year":"2011","unstructured":"Steevens, J., Schouten, L. J., Goldbohm, R. A. & van den Brandt, P. A. Vegetables and fruits consumption and risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study. Int. J. Cancer 129, 2681\u20132693 (2011).","journal-title":"Int. J. Cancer"},{"key":"419_CR88","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/00008469-200108000-00010","volume":"10","author":"P Terry","year":"2001","unstructured":"Terry, P., Lagergren, J., Hansen, H., Wolk, A. & Nyren, O. Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers. Eur. J. Cancer Prev. 10, 365\u2013369 (2001).","journal-title":"Eur. J. Cancer Prev."},{"key":"419_CR89","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3945\/ajcn.2008.26497","volume":"89","author":"OM Thompson","year":"2009","unstructured":"Thompson, O. M., Beresford, S. A., Kirk, E. A. & Vaughan, T. L. Vegetable and fruit intakes and risk of Barrett\u2019s esophagus in men and women. Am. J. Clin. Nutr. 89, 890\u2013896 (2009).","journal-title":"Am. J. Clin. Nutr."},{"key":"419_CR90","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s10654-017-0301-8","volume":"32","author":"N Li","year":"2017","unstructured":"Li, N. et al. Dietary sugar\/starches intake and Barrett\u2019s esophagus: a pooled analysis. Eur. J. Epidemiol. 32, 1007\u20131017 (2017).","journal-title":"Eur. J. Epidemiol."},{"key":"419_CR91","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1080\/10408398.2015.1067596","volume":"57","author":"L Sun","year":"2017","unstructured":"Sun, L., Zhang, Z., Xu, J., Xu, G. & Liu, X. Dietary fiber intake reduces risk for Barrett\u2019s esophagus and esophageal cancer. Crit. Rev. Food Sci. Nutr. 57, 2749\u20132757 (2017).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"419_CR92","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.3945\/jn.113.174664","volume":"143","author":"L Sharp","year":"2013","unstructured":"Sharp, L., Carsin, A. E., Cantwell, M. M., Anderson, L. A. & Murray, L. J. Intakes of dietary folate and other B vitamins are associated with risks of esophageal adenocarcinoma, Barrett\u2019s esophagus, and reflux esophagitis. J. Nutr. 143, 1966\u20131973 (2013).","journal-title":"J. Nutr."},{"key":"419_CR93","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3945\/ajcn.112.043885","volume":"97","author":"AP Keszei","year":"2013","unstructured":"Keszei, A. P., Goldbohm, R. A., Schouten, L. J., Jakszyn, P. & van den Brandt, P. A. Dietary N-nitroso compounds, endogenous nitrosation, and the risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study. Am. J. Clin. Nutr. 97, 135\u2013146 (2013).","journal-title":"Am. J. Clin. Nutr."},{"key":"419_CR94","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10654-014-9895-2","volume":"29","author":"G Behrens","year":"2014","unstructured":"Behrens, G. et al. The association between physical activity and gastroesophageal cancer: systematic review and meta-analysis. Eur. J. Epidemiol. 29, 151\u2013170 (2014).","journal-title":"Eur. J. Epidemiol."},{"key":"419_CR95","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1471-230X-14-101","volume":"14","author":"S Singh","year":"2014","unstructured":"Singh, S., Devanna, S., Edakkanambeth Varayil, J., Murad, M. H. & Iyer, P. G. Physical activity is associated with reduced risk of esophageal cancer, particularly esophageal adenocarcinoma: a systematic review and meta-analysis. BMC Gastroenterol. 14, 101 (2014).","journal-title":"BMC Gastroenterol."},{"key":"419_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190325","volume":"13","author":"JL Petrick","year":"2018","unstructured":"Petrick, J. L. et al. Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR study. PLoS ONE 13, e0190325 (2018).","journal-title":"PLoS ONE"},{"key":"419_CR97","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cgh.2014.08.027","volume":"13","author":"MB Cook","year":"2015","unstructured":"Cook, M. B. et al. Association between circulating levels of sex steroid hormones and Barrett\u2019s esophagus in men: a case-control analysis. Clin. Gastroenterol. Hepatol. 13, 673\u2013682 (2015).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"419_CR98","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/andr.12314","volume":"5","author":"MB Cook","year":"2017","unstructured":"Cook, M. B. et al. Sex steroid hormones in relation to Barrett\u2019s esophagus: an analysis of the FINBAR study. Andrology 5, 240\u2013247 (2017).","journal-title":"Andrology"},{"key":"419_CR99","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/jnci\/djy082","volume":"111","author":"JL Petrick","year":"2019","unstructured":"Petrick, J. L. et al. Associations between prediagnostic concentrations of circulating sex steroid hormones and esophageal\/gastric cardia adenocarcinoma among men. J. Natl Cancer Inst. 111, 34\u201341 (2019).","journal-title":"J. Natl Cancer Inst."},{"key":"419_CR100","doi-asserted-by":"publisher","first-page":"211","DOI":"10.14309\/ajg.0000000000000511","volume":"115","author":"JL Petrick","year":"2020","unstructured":"Petrick, J. L. & Cook, M. B. Do sex hormones underlie sex differences in cancer incidence? Testing the intuitive in esophageal adenocarcinoma. Am. J. Gastroenterol. 115, 211\u2013213 (2020).","journal-title":"Am. J. Gastroenterol."},{"key":"419_CR101","doi-asserted-by":"publisher","first-page":"216","DOI":"10.14309\/ajg.0000000000000446","volume":"115","author":"SH Xie","year":"2020","unstructured":"Xie, S. H. et al. Circulating sex hormone levels and risk of esophageal adenocarcinoma in a prospective study in men. Am. J. Gastroenterol. 115, 216\u2013223 (2020).","journal-title":"Am. J. Gastroenterol."},{"key":"419_CR102","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1016\/j.cgh.2019.11.030","volume":"18","author":"SH Xie","year":"2020","unstructured":"Xie, S. H. et al. Association between levels of hormones and risk of esophageal adenocarcinoma and Barrett\u2019s esophagus. Clin. Gastroenterol. Hepatol. 18, 2701\u20132709.e3 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"419_CR103","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/ijc.28869","volume":"135","author":"K Lagergren","year":"2014","unstructured":"Lagergren, K., Lagergren, J. & Brusselaers, N. Hormone replacement therapy and oral contraceptives and risk of oesophageal adenocarcinoma: a systematic review and meta-analysis. Int. J. Cancer 135, 2183\u20132190 (2014).","journal-title":"Int. J. Cancer"},{"key":"419_CR104","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/j.ejca.2010.03.032","volume":"46","author":"DP Cronin-Fenton","year":"2010","unstructured":"Cronin-Fenton, D. P. et al. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur. J. Cancer 46, 2067\u20132076 (2010).","journal-title":"Eur. J. Cancer"},{"key":"419_CR105","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/cncr.24880","volume":"116","author":"ND Freedman","year":"2010","unstructured":"Freedman, N. D. et al. The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH-AARP cohort. Cancer 116, 1572\u20131581 (2010).","journal-title":"Cancer"},{"key":"419_CR106","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1158\/1940-6207.CAPR-10-0389","volume":"4","author":"C Bodelon","year":"2011","unstructured":"Bodelon, C. et al. Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal women. Cancer Prev. Res. 4, 840\u2013850 (2011).","journal-title":"Cancer Prev. Res."},{"key":"419_CR107","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/bjc.2012.285","volume":"107","author":"Y Lu","year":"2012","unstructured":"Lu, Y. & Lagergren, J. Reproductive factors and risk of oesophageal cancer, a population-based nested case-control study in Sweden. Br. J. Cancer 107, 564\u2013569 (2012).","journal-title":"Br. J. Cancer"},{"key":"419_CR108","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1056\/NEJM199110173251603","volume":"325","author":"J Parsonnet","year":"1991","unstructured":"Parsonnet, J. et al. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325, 1127\u20131131 (1991).","journal-title":"N. Engl. J. Med."},{"key":"419_CR109","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/dote.12194","volume":"27","author":"S Nie","year":"2014","unstructured":"Nie, S., Chen, T., Yang, X., Huai, P. & Lu, M. Association of Helicobacter pylori infection with esophageal adenocarcinoma and squamous cell carcinoma: a meta-analysis. Dis. Esophagus 27, 645\u2013653 (2014).","journal-title":"Dis. Esophagus"},{"key":"419_CR110","doi-asserted-by":"publisher","first-page":"6098","DOI":"10.3748\/wjg.v19.i36.6098","volume":"19","author":"FJ Xie","year":"2013","unstructured":"Xie, F. J. et al. Helicobacter pylori infection and esophageal cancer risk: an updated meta-analysis. World J. Gastroenterol. 19, 6098\u20136107 (2013).","journal-title":"World J. Gastroenterol."},{"key":"419_CR111","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41395-018-0070-3","volume":"113","author":"Z Wang","year":"2018","unstructured":"Wang, Z. et al. Helicobacter pylori infection is associated with reduced risk of Barrett\u2019s esophagus: an analysis of the Barrett\u2019s and Esophageal Adenocarcinoma Consortium. Am. J. Gastroenterol. 113, 1148\u20131155 (2018).","journal-title":"Am. J. Gastroenterol."},{"key":"419_CR112","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12504","volume":"23","author":"B Eross","year":"2018","unstructured":"Eross, B. et al. Helicobacter pylori infection reduces the risk of Barrett\u2019s esophagus: a meta-analysis and systematic review. Helicobacter 23, e12504 (2018).","journal-title":"Helicobacter"},{"key":"419_CR113","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1136\/gutjnl-2013-305997","volume":"63","author":"S Singh","year":"2014","unstructured":"Singh, S., Garg, S. K., Singh, P. P., Iyer, P. G. & El-Serag, H. B. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett\u2019s oesophagus: a systematic review and meta-analysis. Gut 63, 1229\u20131237 (2014).","journal-title":"Gut"},{"key":"419_CR114","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(18)31388-6","volume":"392","author":"JAZ Jankowski","year":"2018","unstructured":"Jankowski, J. A. Z. et al. Esomeprazole and aspirin in Barrett\u2019s oesophagus (AspECT): a randomised factorial trial. Lancet 392, 400\u2013408 (2018).","journal-title":"Lancet"},{"key":"419_CR115","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/apt.14895","volume":"48","author":"MC Tan","year":"2018","unstructured":"Tan, M. C., El-Serag, H. B., Yu, X. & Thrift, A. P. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett\u2019s oesophagus: a nested case-control study in US male veterans. Aliment. Pharmacol. Ther. 48, 469\u2013477 (2018).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"419_CR116","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1053\/j.gastro.2011.11.019","volume":"142","author":"LM Liao","year":"2012","unstructured":"Liao, L. M. et al. Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. Gastroenterology 142, 442\u2013452 (2012).","journal-title":"Gastroenterology"},{"key":"419_CR117","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/ajg.2016.348","volume":"111","author":"AP Thrift","year":"2016","unstructured":"Thrift, A. P. et al. Nonsteroidal anti-inflammatory drug use is not associated with reduced risk of Barrett\u2019s esophagus. Am. J. Gastroenterol. 111, 1528\u20131535 (2016).","journal-title":"Am. J. Gastroenterol."},{"key":"419_CR118","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S1470-2045(05)70431-9","volume":"6","author":"TL Vaughan","year":"2005","unstructured":"Vaughan, T. L. et al. Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett\u2019s oesophagus: a prospective study. Lancet Oncol. 6, 945\u2013952 (2005).","journal-title":"Lancet Oncol."},{"key":"419_CR119","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1158\/1940-6207.CAPR-13-0191-T","volume":"7","author":"SE Choi","year":"2014","unstructured":"Choi, S. E., Perzan, K. E., Tramontano, A. C., Kong, C. Y. & Hur, C. Statins and aspirin for chemoprevention in Barrett\u2019s esophagus: results of a cost-effectiveness analysis. Cancer Prev. Res. 7, 341\u2013350 (2014).","journal-title":"Cancer Prev. Res."},{"key":"419_CR120","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1158\/1055-9965.EPI-07-2852","volume":"17","author":"S Sadeghi","year":"2008","unstructured":"Sadeghi, S. et al. Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus. Cancer Epidemiol. Biomarkers Prev. 17, 1169\u20131178 (2008).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"419_CR121","first-page":"97","volume":"7","author":"DC Farrow","year":"1998","unstructured":"Farrow, D. C. et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol. Biomarkers Prev. 7, 97\u2013102 (1998).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"419_CR122","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1053\/j.gastro.2013.11.046","volume":"146","author":"L Alexandre","year":"2014","unstructured":"Alexandre, L. et al. Statin use is associated with reduced risk of histologic subtypes of esophageal cancer: a nested case-control analysis. Gastroenterology 146, 661\u2013668 (2014).","journal-title":"Gastroenterology"},{"key":"419_CR123","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/j.1442-2050.2012.01412.x","volume":"26","author":"IL Beales","year":"2013","unstructured":"Beales, I. L., Vardi, I., Dearman, L. & Broughton, T. Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study. Dis. Esophagus 26, 838\u2013846 (2013).","journal-title":"Dis. Esophagus"},{"key":"419_CR124","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1053\/j.gastro.2014.04.040","volume":"147","author":"T Nguyen","year":"2014","unstructured":"Nguyen, T., Khalaf, N., Ramsey, D. & El-Serag, H. B. Statin use is associated with a decreased risk of Barrett\u2019s esophagus. Gastroenterology 147, 314\u2013323 (2014).","journal-title":"Gastroenterology"},{"key":"419_CR125","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1053\/j.gastro.2015.07.009","volume":"149","author":"T Nguyen","year":"2015","unstructured":"Nguyen, T., Duan, Z., Naik, A. D., Kramer, J. R. & El-Serag, H. B. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett\u2019s esophagus: a nested case-control study. Gastroenterology 149, 1392\u20131398 (2015).","journal-title":"Gastroenterology"},{"key":"419_CR126","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s10620-015-3869-4","volume":"61","author":"IL Beales","year":"2016","unstructured":"Beales, I. L., Dearman, L., Vardi, I. & Loke, Y. Reduced risk of Barrett\u2019s esophagus in statin users: case-control study and meta-analysis. Dig. Dis. Sci. 61, 238\u2013246 (2016).","journal-title":"Dig. Dis. Sci."},{"key":"419_CR127","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.cgh.2012.12.036","volume":"11","author":"S Singh","year":"2013","unstructured":"Singh, S., Singh, A. G., Singh, P. P., Murad, M. H. & Iyer, P. G. Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett\u2019s esophagus: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 11, 620\u2013629 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"419_CR128","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.cgh.2014.01.028","volume":"12","author":"RE Verbeek","year":"2014","unstructured":"Verbeek, R. E. et al. Familial clustering of Barrett\u2019s esophagus and esophageal adenocarcinoma in a European cohort. Clin. Gastroenterol. Hepatol. 12, 1656\u20131663.e1 (2014).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"419_CR129","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jamaoncol.2016.2054","volume":"2","author":"RE Fecteau","year":"2016","unstructured":"Fecteau, R. E. et al. Association between germline mutation in VSIG10L and familial barrett neoplasia. JAMA Oncol. 2, 1333\u20131339 (2016).","journal-title":"JAMA Oncol."},{"key":"419_CR130","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ajhg.2011.12.008","volume":"90","author":"DC Blaydon","year":"2012","unstructured":"Blaydon, D. C. et al. RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome. Am. J. Hum. Genet. 90, 340\u2013346 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"419_CR131","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/cam4.500","volume":"4","author":"J Becker","year":"2015","unstructured":"Becker, J. et al. Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinoma. Cancer Med. 4, 1700\u20131704 (2015).","journal-title":"Cancer Med."},{"key":"419_CR132","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2014.10.041","volume":"148","author":"C Palles","year":"2015","unstructured":"Palles, C. et al. Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett\u2019s esophagus. Gastroenterology 148, 367\u2013378 (2015).","journal-title":"Gastroenterology"},{"key":"419_CR133","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/ng.2796","volume":"45","author":"DM Levine","year":"2013","unstructured":"Levine, D. M. et al. A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett\u2019s esophagus. Nat. Genet. 45, 1487\u20131493 (2013).","journal-title":"Nat. Genet."},{"key":"419_CR134","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S1470-2045(16)30240-6","volume":"17","author":"P Gharahkhani","year":"2016","unstructured":"Gharahkhani, P. et al. Genome-wide association studies in oesophageal adenocarcinoma and Barrett\u2019s oesophagus: a large-scale meta-analysis. Lancet Oncol. 17, 1363\u20131373 (2016).","journal-title":"Lancet Oncol."},{"key":"419_CR135","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/ng.2408","volume":"44","author":"Z Su","year":"2012","unstructured":"Su, Z. et al. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett\u2019s esophagus. Nat. Genet. 44, 1131\u20131136 (2012).","journal-title":"Nat. Genet."},{"key":"419_CR136","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1158\/1055-9965.EPI-15-0596","volume":"24","author":"E Lee","year":"2015","unstructured":"Lee, E. et al. Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma risk. Cancer Epidemiol. Biomarkers Prev. 24, 1801\u20131803 (2015).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"419_CR137","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/ng.649","volume":"42","author":"CC Abnet","year":"2010","unstructured":"Abnet, C. C. et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat. Genet. 42, 764\u2013767 (2010).","journal-title":"Nat. Genet."},{"key":"419_CR138","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1093\/hmg\/dds029","volume":"21","author":"CC Abnet","year":"2012","unstructured":"Abnet, C. C. et al. Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies. Hum. Mol. Genet. 21, 2132\u20132141 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"419_CR139","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/ng.648","volume":"42","author":"LD Wang","year":"2010","unstructured":"Wang, L. D. et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat. Genet. 42, 759\u2013763 (2010).","journal-title":"Nat. Genet."},{"key":"419_CR140","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/ng.849","volume":"43","author":"C Wu","year":"2011","unstructured":"Wu, C. et al. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat. Genet. 43, 679\u2013684 (2011).","journal-title":"Nat. Genet."},{"key":"419_CR141","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/ng.3064","volume":"46","author":"C Wu","year":"2014","unstructured":"Wu, C. et al. Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations. Nat. Genet. 46, 1001\u20131006 (2014).","journal-title":"Nat. Genet."},{"key":"419_CR142","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/ng.2411","volume":"44","author":"C Wu","year":"2012","unstructured":"Wu, C. et al. Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat. Genet. 44, 1090\u20131097 (2012).","journal-title":"Nat. Genet."},{"key":"419_CR143","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1053\/j.gastro.2013.05.004","volume":"145","author":"DA Corley","year":"2013","unstructured":"Corley, D. A. et al. Impact of endoscopic surveillance on mortality from Barrett\u2019s esophagus-associated esophageal adenocarcinomas. Gastroenterology 145, 312\u2013319 (2013).","journal-title":"Gastroenterology"},{"key":"419_CR144","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1136\/gutjnl-2014-308865","volume":"65","author":"HB El-Serag","year":"2016","unstructured":"El-Serag, H. B. et al. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett\u2019s oesophagus. Gut 65, 1252\u20131260 (2016).","journal-title":"Gut"},{"key":"419_CR145","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/gutjnl-2013-305506","volume":"64","author":"SK Bhat","year":"2015","unstructured":"Bhat, S. K. et al. Oesophageal adenocarcinoma and prior diagnosis of Barrett\u2019s oesophagus: a population-based study. Gut 64, 20\u201325 (2015).","journal-title":"Gut"},{"key":"419_CR146","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1007\/s10620-018-5241-y","volume":"63","author":"TN Wenker","year":"2018","unstructured":"Wenker, T. N., Tan, M. C., Liu, Y., El-Serag, H. B. & Thrift, A. P. Prior diagnosis of Barrett\u2019s esophagus is infrequent, but associated with improved esophageal adenocarcinoma survival. Dig. Dis. Sci. 63, 3112\u20133119 (2018).","journal-title":"Dig. Dis. Sci."},{"key":"419_CR147","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1053\/j.gastro.2013.03.008","volume":"145","author":"M Gupta","year":"2013","unstructured":"Gupta, M. et al. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett\u2019s esophagus: results from a US multicenter consortium. Gastroenterology 145, 79\u201386.e71 (2013).","journal-title":"Gastroenterology"},{"key":"419_CR148","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.cgh.2013.03.039","volume":"11","author":"ES Orman","year":"2013","unstructured":"Orman, E. S., Li, N. & Shaheen, N. J. Efficacy and durability of radiofrequency ablation for Barrett\u2019s esophagus: systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 11, 1245\u20131255 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"419_CR149","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2010.12.019","volume":"140","author":"HB El-Serag","year":"2011","unstructured":"El-Serag, H. B. & Graham, D. Y. Routine polypectomy for colorectal polyps and ablation for Barrett\u2019s esophagus are intellectually the same. Gastroenterology 140, 386\u2013388 (2011).","journal-title":"Gastroenterology"},{"key":"419_CR150","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1053\/j.gastro.2012.05.010","volume":"143","author":"C Hur","year":"2012","unstructured":"Hur, C. et al. The cost effectiveness of radiofrequency ablation for Barrett\u2019s esophagus. Gastroenterology 143, 567\u2013575 (2012).","journal-title":"Gastroenterology"},{"key":"419_CR151","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.gie.2013.07.046","volume":"79","author":"LG Gordon","year":"2014","unstructured":"Gordon, L. G. et al. Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett\u2019s esophagus. Gastrointest. Endosc. 79, 242\u2013256.e6 (2014).","journal-title":"Gastrointest. Endosc."},{"key":"419_CR152","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S2468-1253(16)30118-2","volume":"2","author":"CS Ross-Innes","year":"2017","unstructured":"Ross-Innes, C. S. et al. Risk stratification of Barrett\u2019s oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study. Lancet Gastroenterol. Hepatol. 2, 23\u201331 (2017).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"419_CR153","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4664-3","volume":"18","author":"J Offman","year":"2018","unstructured":"Offman, J. et al. Barrett\u2019s Oesophagus Trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux. BMC Cancer 18, 784 (2018).","journal-title":"BMC Cancer"},{"key":"419_CR154","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.cgh.2018.09.026","volume":"17","author":"PN Thota","year":"2019","unstructured":"Thota, P. N. & Chak, A. Is mass screening for Barrett\u2019s esophagus a myth or reality? Clin. Gastroenterol. Hepatol. 17, 610\u2013612 (2019).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"419_CR155","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/SLA.0000000000001101","volume":"262","author":"S Kumar","year":"2015","unstructured":"Kumar, S. et al. Mass spectrometric analysis of exhaled breath for the identification of volatile organic compound biomarkers in esophageal and gastric adenocarcinoma. Ann. Surg. 262, 981\u2013990 (2015).","journal-title":"Ann. Surg."},{"key":"419_CR156","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(20)31099-0","volume":"396","author":"RC Fitzgerald","year":"2020","unstructured":"Fitzgerald, R. C. et al. Cytosponge-trefoil factor 3 versus usual care to identify Barrett\u2019s oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial. Lancet 396, 333\u2013344 (2020).","journal-title":"Lancet"},{"key":"419_CR157","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.cgh.2018.07.019","volume":"17","author":"SS Sami","year":"2019","unstructured":"Sami, S. S. et al. Acceptability, accuracy, and safety of disposable transnasal capsule endoscopy for Barrett\u2019s esophagus screening. Clin. Gastroenterol. Hepatol. 17, 638\u2013646.e1 (2019).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"419_CR158","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1158\/1055-9965.EPI-12-1347","volume":"22","author":"PR Taylor","year":"2013","unstructured":"Taylor, P. R., Abnet, C. C. & Dawsey, S. M. Squamous dysplasia\u2013the precursor lesion for esophageal squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 22, 540\u2013552 (2013).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"419_CR159","doi-asserted-by":"publisher","first-page":"7933","DOI":"10.3748\/wjg.v21.i26.7933","volume":"21","author":"MJ Domper Arnal","year":"2015","unstructured":"Domper Arnal, M. J., Ferr\u00e1ndez Arenas, \u00c1. & Lanas Arbeloa, \u00c1. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J. Gastroenterol. 21, 7933\u20137943 (2015).","journal-title":"World J. Gastroenterol."},{"key":"419_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/srep35707","volume":"6","author":"Q Chen","year":"2016","unstructured":"Chen, Q. et al. Effectiveness evaluation of organized screening for esophageal cancer: a case-control study in Linzhou city, China. Sci. Rep. 6, 35707 (2016).","journal-title":"Sci. Rep."},{"key":"419_CR161","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/ajg.2012.446","volume":"108","author":"JH Rubenstein","year":"2013","unstructured":"Rubenstein, J. H. et al. Prediction of Barrett\u2019s esophagus among men. Am. J. Gastroenterol. 108, 353\u2013362 (2013).","journal-title":"Am. J. Gastroenterol."},{"key":"419_CR162","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.cgh.2013.12.014","volume":"12","author":"AP Thrift","year":"2014","unstructured":"Thrift, A. P., Garcia, J. M. & El-Serag, H. B. A multibiomarker risk score helps predict risk for Barrett\u2019s esophagus. Clin. Gastroenterol. Hepatol. 12, 1267\u20131271 (2014).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"419_CR163","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1053\/j.gastro.2017.12.003","volume":"154","author":"J Dong","year":"2018","unstructured":"Dong, J. et al. Determining risk of Barrett\u2019s esophagus and esophageal adenocarcinoma based on epidemiologic factors and genetic variants. Gastroenterology 154, 1273\u20131281 (2018).","journal-title":"Gastroenterology"},{"key":"419_CR164","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1053\/j.gastro.2020.02.037","volume":"158","author":"JH Rubenstein","year":"2020","unstructured":"Rubenstein, J. H. et al. Validation and comparison of tools for selecting individuals to screen for Barrett\u2019s esophagus and early neoplasia. Gastroenterology 158, 2082\u20132092 (2020).","journal-title":"Gastroenterology"},{"key":"419_CR165","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1158\/1940-6207.CAPR-12-0010","volume":"5","author":"AP Thrift","year":"2012","unstructured":"Thrift, A. P., Kendall, B. J., Pandeya, N., Vaughan, T. L. & Whiteman, D. C. A clinical risk prediction model for Barrett esophagus. Cancer Prev. Res. 5, 1115\u20131123 (2012).","journal-title":"Cancer Prev. Res."},{"key":"419_CR166","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bpg.2014.11.009","volume":"29","author":"JH Rubenstein","year":"2015","unstructured":"Rubenstein, J. H. & Thrift, A. P. Risk factors and populations at risk: selection of patients for screening for Barrett\u2019s oesophagus. Best Pract. Res. Clin. Gastroenterol. 29, 41\u201350 (2015).","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"419_CR167","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.cgh.2016.08.026","volume":"14","author":"AP Thrift","year":"2016","unstructured":"Thrift, A. P., Kanwal, F. & El-Serag, H. B. Prediction models for gastrointestinal and liver diseases: too many developed, too few validated. Clin. Gastroenterol. Hepatol. 14, 1678\u20131680 (2016).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"419_CR168","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.cgh.2017.03.004","volume":"15","author":"AP Thrift","year":"2017","unstructured":"Thrift, A. P., Vaughan, T. L., Anderson, L. A., Whiteman, D. C. & El-Serag, H. B. External validation of the Michigan Barrett\u2019s Esophagus Prediction Tool. Clin. Gastroenterol. Hepatol. 15, 1124\u20131126 (2017).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"419_CR169","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1007\/s10620-019-06018-2","volume":"65","author":"CJ Ireland","year":"2020","unstructured":"Ireland, C. J., Thrift, A. P. & Esterman, A. Risk prediction models for Barrett\u2019s esophagus discriminate well and are generalizable in an external validation study. Dig. Dis. Sci. 65, 2992\u20132999 (2020).","journal-title":"Dig. Dis. Sci."},{"key":"419_CR170","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cgh.2012.10.026","volume":"11","author":"AP Thrift","year":"2013","unstructured":"Thrift, A. P., Kendall, B. J., Pandeya, N. & Whiteman, D. C. A model to determine absolute risk for esophageal adenocarcinoma. Clin. Gastroenterol. Hepatol. 11, 138\u2013144 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"419_CR171","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1053\/j.gastro.2018.09.038","volume":"156","author":"AT Kunzmann","year":"2019","unstructured":"Kunzmann, A. T. et al. Information on genetic variants does not increase identification of individuals at risk of esophageal adenocarcinoma compared to clinical risk factors. Gastroenterology 156, 43\u201345 (2019).","journal-title":"Gastroenterology"},{"key":"419_CR172","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cgh.2018.03.014","volume":"16","author":"AT Kunzmann","year":"2018","unstructured":"Kunzmann, A. T. et al. Model for identifying individuals at risk for esophageal adenocarcinoma. Clin. Gastroenterol. Hepatol. 16, 1229\u20131236 (2018).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"419_CR173","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1053\/j.gastro.2017.12.009","volume":"154","author":"S Parasa","year":"2017","unstructured":"Parasa, S. et al. Development and validation of a model to determine risk of progression of Barrett\u2019s esophagus to neoplasia. Gastroenterology 154, 1282\u20131289 (2017).","journal-title":"Gastroenterology"},{"key":"419_CR174","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1111\/apt.15235","volume":"49","author":"AT Kunzmann","year":"2019","unstructured":"Kunzmann, A. T. et al. External validation of a model to determine risk of progression of Barrett\u2019s oesophagus to neoplasia. Aliment. Pharmacol. Ther. 49, 1274\u20131281 (2019).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"419_CR175","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1158\/1055-9965.EPI-10-0012","volume":"19","author":"H Pohl","year":"2010","unstructured":"Pohl, H., Sirovich, B. & Welch, H. G. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol. Biomarkers Prev. 19, 1468\u20131470 (2010).","journal-title":"Cancer Epidemiol. Biomarkers Prev."}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41575-021-00419-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-021-00419-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-021-00419-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T07:08:11Z","timestamp":1674976091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41575-021-00419-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":175,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["419"],"URL":"https:\/\/doi.org\/10.1038\/s41575-021-00419-3","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,18]]},"assertion":[{"value":"14 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}